Elevated expression of H type GDP-L-fucose:β-D-galactoside α-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression

GDP-L-fucose:β-D-galactoside α-2-L-fucosyltransferase (EC 2.4.1.69) is a key enzyme in the biosynthesis of fucosylated type 1 and 2 lactoseries structures, such as Lewis b and the H type 2 and Lewis Y, respectively, that are accumulated in colon adenocarcinoma. Analysis of the mRNA transcript level for the human H gene-encoded β-D-galactoside α-2-L-fucosyltransferase revealed 40- and 340-fold increases in the mRNA levels in all adenocarcinomas and tumor cell lines, respectively, compared to normal colon mucosa where a low level of mRNA transcript was detected. A variable increase in mRNA transcript levels was observed in 50% of adenomatous polyps. Nucleotide sequence analysis of the protein coding region of the cDNAs derived from normal colon, adenoma, and colon adenocarcinoma revealed 100% homology, suggesting that there are no tumor-associated allelic variations within the H β-D-galactoside α-2-L-fucosyltransferase cDNA. These results suggest that β-D-galactoside α-2-L-fucosyltransferase expression highly correlates with malignant progression of colon adenocarcinoma.